Eder Martins, VP, US Franchise Head – Lung Cancer at AstraZeneca shared a post on LinkedIn:
“I am happy to share the next chapter of my AstraZeneca journey as Vice President, US Franchise Head – Lung Cancer.
AstraZeneca has a long legacy of bringing transformative medicines to patients, and I am honored to lead our efforts in such a critical disease area. I look forward to continuing our work alongside our talented teams, external partners, and the lung cancer community.
While lung cancer remains a significant healthcare challenge, I am incredibly proud of how we are fundamentally changing the way patients fight this disease-not just through new medicines, but by elevating the standard of care to improve long-term outcomes.
My sincere thanks to Arun Krishna, Mohit Manrao, and David Fredrickson for your mentorship and trust in me to lead this franchise through its next phase of growth.
And to my team: it has been an amazing ride so far. I am so proud of what we’ve achieved together, and I’m even more excited for what’s to come.
Onward!”
Other articles about Lung Cancer on OncoDaily.